Bayforest Capital »

Dianthus Therapeutics shares owned by Bayforest Capital

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Bayforest Capital from 13F filings

Historical chart of Bayforest Capital investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Bayforest Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Bayforest Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $196k 2.0k 97.48

More positions owned by Bayforest Capital

Slide Ins Hldgs (SLDE)
Alexandria Real Estate Equities (ARE)
Perimeter Solutions Common Stock (PRM)
NetApp (NTAP)
Talos Energy (TALO)
Asbury Automotive (ABG)
C3 Ai Cl A (AI)
Solaredge Technologies (SEDG)
Hinge Health Cl A (HNGE)
Millrose Pptys Com Cl A (MRP)
Chord Energy Corporation Com New (CHRD)
A Mark Precious Metals (GOLD)
Bandwidth Com Cl A (BAND)
Perrigo SHS (PRGO)
Northern Oil And Gas Inc Mn (NOG)

View all positions for Bayforest Capital

Top funds holding Dianthus Therapeutics

FMR
BlackRock
Wellington Management Company
Fairmount Funds Management
Vanguard Capital Management
Avidity Partners Management
Octagon Capital Advisors
TCG Crossover Management
State Street Corporation
Fred Alger Management
Geode Capital Management
VR Adviser
T. Rowe Price Associates
UBS Group
Deerfield Management Company

View all funds holding Dianthus Therapeutics